跳到主要內容區塊
:::

李佳榮 博士

Print
        Art editor Img

    李佳榮 博士 

    Chia-Jung Li, Ph.D.

     

    Office: +886-7-342-2121 #71562

    Lab: +886-7-342-2121 #74048

    Associate Research Fellow
    副研究員
    Email: cjli@vghks.gov.tw

    Education and Experience / 學經歷

    • 2019 – Present Associate Research Fellow / Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Taiwan. / 高雄榮總婦女醫學部  副研究員
    • 2020 – ssociate Professor, Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Taiwan / 國立中山大學生技醫藥研究所 合聘副教授
    • 2020 – Assistant Professor / 教育部頒定助理教授
    • 2017 – 2019 Researcher & Team Leader / Research Assistance Center, Show Chwan Memorial Hospital, Taiwan. / 秀傳紀念醫院醫研部  研究員兼組長
    • 2017 – 2019 Executive editor, Show Chwan Medical Journal. / 秀傳醫學雜誌  執行編輯
    • 2015 – 2017 Postdoctoral Research Fellow, Ministry of Science and Technology (MOST), National Cheng Kung University, Institute of Clinical Medicine, Taiwan. / 國立成功大學臨床醫學研究所  博士後研究員
    • 2015 Ph.D., Institute of Medical Sciences, Tzu Chi University, Taiwan. / 慈濟大學  醫學科學研究所 博士

    Editor & Reviewer / 期刊編輯與審查

    Lead Guest Editor / 客座主編:

    List of Journals Reviewed / 期刊審查委員

    • Journal of Advanced Research (IF: 6.992)
    • Cancers (IF: 6.162)
    • Journal of Clinical Medicine (IF: 5.688)
    • Cells (IF: 5.656)
    • Journal of Experimental and Clinical Cancer Research (IF: 5.646)
    • Cancer Biology & Medicine (IF: 5.432)
    • Antioxidants (IF: 5.014)
    • Aging (IF: 4.813)
    • Biomolecules (IF: 4.694)
    • Journal of Oncology (IF: 4.593)
    • International Journal of Molecular Sciences (IF: 4.183)
    • Nutrients (IF: 4.171)
    • Neurotoxicity Research (IF: 3.538)
    • OncoTargets and Therapy (IF: 2.311)
    • Evidence-Based Complementary and Alternative Medicine (IF: 2.064)
    • Medical Science Monitor (IF: 1.433)

    Awards & Distinctions / 獎項 & 榮譽

    1. 2020 - Outstanding Research Award. The 5th Taiwan Breast Cancer Foundation, Taiwan. / 獲選乳癌防治基金會優秀論文獎
    2. 2020 - Outstanding Poster Award. Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine (TSMRM), Taiwan. / 獲選粒線體研討會優秀論文獎
    3. 2020 - Best Paper Award. The Taipei International Breast Cancer Symposium (TIBCS), Taiwan / 獲選台北國際乳癌研討會優秀論文獎
    4. 2020 - Prize Paper Award. Annual Meeting of Taiwanese Society for Reproductive Medicine (TSRM), Taiwan. / 獲選生殖醫學年會優秀口頭論文獎
    5. 2020 - Invited Speaker. The 10th congress of the Asia pacific initiative on reproduction (ASPIRE) Philippine international convention center, Philippine. / 受邀為亞太生殖醫學研討會大會講者
    6. 2019 - Outstanding Research Award. The 4th Taiwan Breast Cancer Foundation, Taiwan. / 獲選乳癌防治基金會優秀論文獎
    7. 2019 - Our research has been selected as a Cover Story in the Theranostics (IF: 8.063). Vol:9, Issue:22. / 論文獲選為該期封面故事
    8. 2019 - Prize Paper Award. Annual Meeting of Taiwanese Society for Reproductive Medicine (TSRM), Taiwan. / 獲選生殖醫學年會口頭論文競賽第一名
    9. 2019 - Invited Speaker. Taiwan society of laboratory medicine, Kaohsiung Medical University, Taiwan. / 受邀至台灣醫事檢驗年會演講
    10. 2019 - Our research has been selected as a Cover Story in the Journal of Clinical Medicine (IF: 5.688). Vol:8, Issue:4. / 論文獲選為該期封面故事
    11. 2019 - Invited Speaker. Department of Medical Research and Development, Tainan Municipal Hospital, Taiwan. / 受邀至台南市立醫院全院性演講
    12. 2018 - Outstanding Poster Award. Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine (TSMRM), Taiwan. / 獲選粒線體研討會傑出論文獎
    13. 2018 - Our research has been selected as a Cover Story in the Journal of Clinical Medicine (IF: 5.688). Vol:7, Issue:8. / 論文獲選為該期封面故事
    14. 2018 - Invited Speaker. Department of Research, Taichung Tzu Chi Hospital, Taiwan. / 受邀至台中慈濟醫院醫研部演講
    15. 2017 - Invited Speaker. Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine (TSMRM), Kaohsiung Chang Gung Memorial Hospital, Taiwan. / 受邀為粒線體醫學研討會大會講者
    16. 2017 - Invited Speaker. Department of Medical Research and Development, Tainan Municipal Hospital, Taiwan. / 受邀至台南市立醫院全院性演講
    17. 2016 - Travel Award (Tokyo, Japan). Ministry of Science and Technology (MOST), Taiwan. Grants for Post-doctorates attending international conferences. / 獲科技部補助專家學者出席國際會議
    18. 2016 - Travel Award (Tokyo, Japan). The Chinese Society of Cell and Molecular Biology, Taiwan. / 獲細胞分子生物學會補助專家學者出席國際會議
    19. 2016 - Invited Speaker. The 3rd International Conference on Biomedical Engineering and  Pharmaceutical Sciences (ICBEPS), Nanjing, China. / 受邀為中國南京國際會議大會講者
    20. 2014 - Merit Poster Award. The 11th Conference of Asian Society for Mitochondrial Research and Medicine (ASMRM): Mitochondrial Research from Bench to Clinic, Taiwan. / 獲選亞洲粒線體研討會傑出論文獎
    21. 2014 - Outstanding Thesis Presentation Award. The 4th Annual Symposium of Tzu Chi Academy, Taiwan. / 獲選慈濟學術會議傑出論文獎
    22. 2012 - Outstanding Poster Award. Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine (TSMRM), Taiwan. / 獲選粒線體研討會傑出論文獎
    23. 2012 - Travel Award (Boston, USA). The Chinese Society of Cell and Molecular Biology, Taiwan. 獲細胞分子生物學會補助專家學者出席國際會議
    24. 2011 - Travel Award. 1st Workshop on Systems Biology of Tumor Dormancy, MA. USA. / 獲美國會議補助專家學者出席國際會議


    List of Publications / 論文著述

    1. Wu MY, Lai TT, Liao WT, Li CJ*. Clinicopathological and prognostic significance and molecular mechanism in uveal melanoma. Ther Adv Med Oncol. 12:1. IF – 6.852. 2020.
    2. Lin PS, Lin LT, Li CJ, Kao PG, Tsai HW, Chen SN, Wen ZH, Wang PH, Tusi KH. Combining Bioinformatics and Experiments to Identify CREB1 as a Key Regulator in Senescent Granulosa Cells. Diagnostics. 10:295. IF – 3.110. 2020.
    3. Tsui KH, Wu MY, Lin LT, Wen ZH, Li YH, Chu PY*, Li CJ*. Disruption of mitochondrial homeostasis with artemisinin unravels anti-angiogenesis effects via auto-paracrine mechanisms. Theranostics. 9:6631. IF – 8.063. (Cover story). 2019.
    4. Li CJ, Chu PY, Yiang GT, Wu MY. The molecular mechanism of epithelial-mesenchymal transition for breast carcinogenesis. Biomolecules. 9:E476. IF – 4.694. 2019.
    5. Wang CN, Li CY, Cai JH, Sheu CY, Tsai JP, Wu MY, Li CJ*, Hou MF*. Identification of prognostic candidate genes in breast cancer by integrated bioinformatic Analysis. J Clin Med. 8:1160. IF – 5.688. 2019.
    6. Liao WT, Su CC, Lee MT, Li CJ, Lin CL, Chiang JH, Yen HR. Integrative Chinese herbal medicine therapy reduced the risk of type 2 diabetes mellitus in patients with polycystic ovary syndrome: A nationwide matched cohort study. J Ethnopharmacol. 243:112091. IF – 3.414. 2019.
    7. Ko CJ, Li CJ, Wu MY, Chu PY. Overexpression of LGR-5 as a predictor of poor outcome in patients with hepatocellular carcinoma. J Environ Res Public Health. 16:1836. IF – 2.468. 2019.
    8. Chen SN, Chang R, Lin LT, Chern CU, Tsai HW, Wen ZH, Li YH, Li CJ, Tsui KH. MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities. Int J Environ Res Public Health. 16:1510. IF – 2.468. 2019.
    9. Li CJ, Chen CS, Yiang GT, Tsai PY, Liao WT, Wu MY. Advanced evolution of pathogenesis concepts in cardiomyopathies. J Clin Med. 8:520. IF – 5.688. (Cover story). 2019.
    10. Chiu HC, Li CJ, Yiang GT, Tsai PY, Wu MY. EMT and cell biology of molecular regulation in endometrial carcinogenesis. J Clin Med. 8:439. IF – 5.688. 2019.
    11. Li CJ, Chen SN, Lin LT, Chern CU, Wang PH, Wen ZH, Tsui KH. DHEA modulates abnormal mitochondrial dynamics and mitophagy of cumulus Cells in poor ovarian responders. J Clin Med. 7:293. IF – 5.688. 2018.
    12. Wu MY, Yiang GT, Chen YL, Li CJ*, Lin SC*. Clinical outcome and management for geriatric traumatic injury: analysis of 2688 cases in emergency department at a teaching hospital in Taiwan. J Clin Med. 7:255. IF –5.688. 2018.
    13. Wang SC, Wang SC, Li CJ, Lin CH, Huang HL, Tsai LM, Chang CH. The therapeutic effects of traditional Chinese medicine for poor semen quality in infertile males. J Clin Med. 7:239. IF – 5.688. 2018.
    14. Wu MY, Chen CS, Yiang GT, Cheng PW, Chiu HC, Liu KH, Lee WC, Li CJ*. 2018. The Emerging Role of Pathogenesis of IgA Nephropathy. J Clin Med. 7:225. IF – 5.688. 2018.
    15. Wu MY, Yiang GT, Lai TT, Li CJ*. The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy. Oxid Med and Cell Longev. 2018:3420187. IF – 4.868. 2018.
    16. Wu MY, Yiang GT, Cheng PW, Chu PY, Li CJ*. Molecular targets in hepatocarcinogenesis and implications for therapy. J Clin Med. 7, 213. IF – 5.688. (Cover story). 2018.
    17. Chiu HC, Wu MY, Li CH, Huang SC, Yiang GT, Yen HS, Liu WL, Li CJ*, Kao WY*. EMT with malignant transformation leading multiple metastasis from leiomyomatosis peritonealis disseminata. J Clin Med. 7:207. IF –5 .688. 2018.
    18. Ko CJ, Li CJ, Wu MY, Chu PY. Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma. Exp Ther Med. 16:4810. IF – 1.448. 2018.
    19. Liao WT, Chiang JH, Li CJ, Lee MT, Su CC, Yen HR. Investigation on the use of traditional Chinese medicine for polycystic ovary syndrome in a nationwide prescription database in Taiwan. J Clin Med. 7:179. IF – 5.688. 2018.
    20. Wu MY, Lee LC, Chen YL, Yeh YH, Li CJ*, Yiang GT*. Septic pulmonary emboli or pulmonary metastasis in a patient with diabetes mellitus? J Clin Med. 7:176. IF – 5.688. 2018.
    21. Yang CY, Chen CS, Yiang GT, Cheng YL, Yong SB, Wu MY, Li CJ*. New insights into the immune molecular regulation of the pathogenesis of acute respiratory distress syndrome. Int J Mol Sci. 19:588. IF – 4.183. 2018.
    22. Wu MY, Yiang GT, Liao WT, Tsai PY, Cheng PW, Li CY, Li CJ*. Current concepts of the mechanism in ischemia and reperfusion injury. Cell Physiol Biochem. 46:1650. IF – 5.5. 2018.
    23. Wu MY#, Li CJ#, Yiang GT, Hou YT, Hou MF, Chu PY. # co-first. Molecular regulation of bone metastasis pathogenesis. Cell Physiol Biochem. 46:1423. IF – 5.5. 2018.
    24. Lin SC, Chu PY, Liao WT, Wu MY, Tsui KH, Chen LL, Li CJ*. Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway. Oncol Rep. 39:703. IF – 3.041. 2018.
    25. Wu MY, Li CJ, MF Hou, Chu PY. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci. 18:2034. IF – 4.183. 2017.
    26. Li CJ, Liao WT, Wu MY, Chu PY. New insights into the role of autophagy in tumor immune microenvironment. Int J Mol Sci. 18:1566. IF – 4.183. 2017.
    27. Lin LT, Chen JT, Chao KC, Li CJ, Tsui KH. Dehydroepiandrosterone as a potential agent to slow down ovarian aging. J Obstet Gynaecol Res. 43: 1855. IF – 1.099. 2017.
    28. Li CJ, Chen PK, LY Sun, Pang CY. Enhancement of mitochondrial transfer by antioxidants in human mesenchymal stem cells. Oxid Med and Cell Longev. 2017:851085. IF – 4.868. 2017.
    29. Lin LT, Wang PH, Wen ZH, Li CJ, Chen SN, Tsai EM, Cheng JT, Tsui KH. The application of DHEA on improving mitochondrial function and reducing apoptosis of cumulus cells in poor ovarian responders. Int J Med Sci. 14: 585. IF – 2.284. 2017.
    30. Tsui KH, Wang PH, Lin LT, Li CJ. DHEA protect mitochondria against dual modes of apoptosis and necroptosis in granulosa cells. Reproduction. 154:101. IF – 3.125. 2017.
    31. Lin LT, Wang PH, Chen SN, Li CJ, Wen ZH, Cheng JT, Tsui KH. Protection of cumulus cells following DHEA supplementation. Gynecol Endocrinol. 33: 100. IF – 1.585. 2016.
    32. Li CJ, LY Sun, Pang CY. Synergistic protection of N-acetylcysteine and ascorbic acid 2-phosphate on human mesenchymal stem cells against mitoptosis, necroptosis and apoptosis. Sci Rep. 5: 9819. IF – 4.122. 2015.
    33. Li CJ, Chu CY, Huang LH, Wang MH, Sheu LF, Yeh JI, Hsu HY. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo. Cancer Lett. 319: 203. IF – 6.508. 2012.
    34. Li CJ, Tsang SF, Tsai CH, Tsai HY, Chyuan JH, Hsu HY. Momordica charantia-induced extract induces apoptosis in human cancer cells through caspase-dependent and mitochondria-dependent pathway. Evid Based Complement Alternat Med. 2012: 261971. IF – 2.064. 2012.
    35. Li CJ, Huang SY, Wu MY, Chen YC, Tsang SF, Chyuan JH, Hsu HY. Induction of apoptosis by ethanolic extract of Corchorus olitorius leaf in human hepatocellular carcinoma (HepG2) cells via a mitochondria dependent pathway. Molecules. 17: 9348. IF – 3.098. 2012.
    36. Tseng HL, Li CJ, Chen CY, Huang LH, Lin CN, Hsu HY. Quercetin 3-O-methyl ether protects FL83B cells from copper induced oxidative stress through the PI3K/Akt and MAPK/Erk pathway. Toxicol Appl Pharmacol. 264: 104. IF – 3.705. 2012.
    37. Hsu HY, Lin JH, Li CJ, Tsang SF, Tsai CH, Chyuan JH, Chiu SJ, Chuang SE. Anti-migratory effects of the methanol-extract from Momordica charantia on human lung adenocarcinoma CL1 cells. Evid Based Complement Alternat Med. 2012: 819632. IF – 2.064. 2012.
    38. Huang WT, Li CJ, Wu PJ, Chang YS, Lee TL, Weng CF. Expression and in vitro regulation of pituitary adenylate cyclase-activating polypeptide (PACAP38) and its type I receptor (PAC1-R) in the gonads of tilapia (Oreochromis mossambicus). Reproduction. 137: 449. IF – 3.125. 2009.

     

     

    創用cc:姓名標示
    相關文章
    :::